Coherus Oncology Inc (CHRS)

Pre-Tax Margin

-233.08%

Quarterly · Period ending:

CHRS logo

CHRS Pre-Tax Margin

Latest reported-233.08%
CHRS Quarterly Pre-Tax Margin (-1751.38% → -233.08%)
High-resolution chart · PNG

CHRS pre-tax margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Pre-Tax Margin — Quarterly
Period endingPre-Tax Margin
-233.0817%
-300.0406%
-363.5629%
-384.7291%
-437.5073%
-623.74%
-93.6318%
-15.1906%
-19.8849%
-2,947.8336%
-87.0296%
-53.6705%
-73.0108%
-233.4721%
-129.8068%
-190.7582%
-83.3735%
-159.8337%
-62.3203%
-46.6989%
-34.1157%
-208.2846%
9.7447%
24.7607%
44.4632%
31.4211%
33.3218%
42.8799%
28.3077%
-53.922%
0%
0%
0%
0%
0%
0%
-3,971.4695%
-46,473.2919%
-8,998.1043%
51.4902%
-498.6494%
-530.2856%
-515.5913%
-997.4187%
-859.8019%
-702.9088%
-446.9891%
-49.3023%
-504.9345%
-699.9444%
-1,184.3344%
-4,243.6759%
-1,717.7515%
-1,751.3834%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.